학술논문

CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
Document Type
article
Source
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2051-1426